Zephyr AI

Meet Zong Miao! 👋
As our Senior Bioinformatics Scientist, Zong develops bioinformatics pipelines and new algorithms for next-generation sequencing (NGS) data. He also works in close collaboration with our biologists, data scientists, and engineers to develop our prediction model.

"I enjoy the fact that the job is highly multidisciplinary where I can learn from experts in many different areas. The goal to facilitate drug development with AI and the potential impact on broad patients also motivate me."

We are excited to have you on the , Zong!

Advancements in technology have become such an integral part in providing better patient outcomes. With cutting-edge algorithms and capabilities, we are unlocking an unprecedented level of accurate care. This serves as an encouraging sign of what we can expect for the future of healthcare.

CEO, Satya Nadella said it best⎯

In a written piece from , AI utilization may be the key to unlocking important information about statins and diabetes.
By conducting a large-scale analysis of unstructured electronic health record (EHR) data, providers can gain a better understanding of statin nonuse to determine how best to improve patient outcomes.

As a company working to better the lives of those living with  , it is encouraging to witness the power of   technology being harnessed for more patient-centric applications.

Read the full article with the link in our bio!

On this Employee Appreciation Day, we’d like to take a moment to recognize our amazing employees who make Zephyr AI possible.

We are proud of this team today and every day for your commitment and dedication.